| Literature DB >> 25463973 |
T Shah1, G Verdile2, H Sohrabi1, A Campbell3, E Putland4, C Cheetham5, S Dhaliwal6, M Weinborn7, P Maruff8, D Darby9, R N Martins1.
Abstract
Physical exercise interventions and cognitive training programs have individually been reported to improve cognition in the healthy elderly population; however, the clinical significance of using a combined approach is currently lacking. This study evaluated whether physical activity (PA), computerized cognitive training and/or a combination of both could improve cognition. In this nonrandomized study, 224 healthy community-dwelling older adults (60-85 years) were assigned to 16 weeks home-based PA (n=64), computerized cognitive stimulation (n=62), a combination of both (combined, n=51) or a control group (n=47). Cognition was assessed using the Rey Auditory Verbal Learning Test, Controlled Oral Word Association Test and the CogState computerized battery at baseline, 8 and 16 weeks post intervention. Physical fitness assessments were performed at all time points. A subset (total n=45) of participants underwent [(18)F] fluorodeoxyglucose positron emission tomography scans at 16 weeks (post-intervention). One hundred and ninety-one participants completed the study and the data of 172 participants were included in the final analysis. Compared with the control group, the combined group showed improved verbal episodic memory and significantly higher brain glucose metabolism in the left sensorimotor cortex after controlling for age, sex, premorbid IQ, apolipoprotein E (APOE) status and history of head injury. The higher cerebral glucose metabolism in this brain region was positively associated with improved verbal memory seen in the combined group only. Our study provides evidence that a specific combination of physical and mental exercises for 16 weeks can improve cognition and increase cerebral glucose metabolism in cognitively intact healthy older adults.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25463973 PMCID: PMC4270308 DOI: 10.1038/tp.2014.122
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 6.222
Figure 1Flow of participants from screening to completion of the 16 weeks post-intervention follow-up assessment.
Baseline demographics, clinical characteristics and assessments for entire cohort and the four intervention groupsa
| P- | ||||||
|---|---|---|---|---|---|---|
| Age | 67.60±5.42 | 67.36±5.09 | 66.61±4.82 | 67.18±5.33 | 69.06±5.59 | 0.187 |
| Females, | 153 (68.92) | 29 (69.00) | 32 (62.70) | 29 (65.90) | 26 (74.30) | 0.716 |
| Education (PG), | 35 (15.98) | 5 (11.90) | 11 (22.00) | 6 (13.60) | 6 (17.10) | 0.094 |
| Retired, | 167 (75.57) | 34 (81.00) | 35 (68.60) | 32 (72.70) | 29 (82.90) | 0.531 |
| High blood pressure, | 75 (34.09) | 11 (26.20) | 16 (31.40) | 14 (31.80) | 16 (45.70) | 0.318 |
| Heart attack, | 8 (03.62) | 0 (00.00) | 0 (00.00) | 2 (04.50) | 3 (08.60) | 0.066 |
| Diabetes, | 26 (11.76) | 6 (14.30) | 5 (09.80) | 4 (09.10) | 4 (11.40) | 0.589 |
| Visual defects, | 132 (59.73) | 20 (47.60) | 34 (66.70) | 28 (63.60) | 19 (54.30) | 0.242 |
| History of falls, | 15 (06.79) | 4 (09.50) | 5 (09.80) | 3 (06.80) | 2 (05.70) | 0.879 |
| Thyroid, | 34 (15.38) | 10 (23.80) | 3 (05.90) | 7 (15.90) | 6 (17.10) | 0.112 |
| Arthritis, | 91 (41.18) | 14 (33.30) | 22 (43.10) | 18 (40.90) | 11 (31.40) | 0.624 |
| Joint replacement, | 20 (09.05) | 2 (04.80) | 5 (09.80) | 4 (09.10) | 1 (02.90) | 0.539 |
| Head injury, | 10 (04.52) | 1 (02.40) | 4 (07.80) | 1 (02.30) | 1 (02.90) | 0.447 |
| Depression, | 37 (16.82) | 7 (17.10) | 10 (19.60) | 3 (06.80) | 5 (14.30) | 0.339 |
| Anxiety, | 31 (14.09) | 5 (12.20) | 5 (09.80) | 6 (13.60) | 6 (17.10) | 0.792 |
| Smoking, | 12 (05.45) | 1 (02.40) | 3 (05.90) | 3 (06.80) | 2 (05.90) | 0.806 |
| Premorbid IQ (CCRT) | 38.13±6.46 | 37.29±6.80 | 38.39±6.33 | 40.25±4.40 | 38.26±6.53 | 0.149 |
| BMI ( | 27.28±4.81 | 26.60±4.42 | 28.08±4.57 | 27.00±5.10 | 26.51±4.16 | 0.373 |
| IPAQ ( | 4431.63±4536.96 | 4432.11±5064.37 | 4294.36±4042.81 | 4749.62±5326.22 | 3673.00±3157.38 | 0.773 |
| APOE ɛ4 carriers, | 65 (29.41) | 14 (33.30) | 18 (35.30) | 17 (38.60) | 3 (08.60) | |
| Total sum of strength (kg)
( | 191.39±58.18 | 193.81±53.51 | 205.11±63.14 | 204.43±57.01 | 168.24±54.03 | 0.062 |
| Distance ( | 470.52±138.01 | 501.19±129.28 | 466.38±114.62 | 485.68±136.29 | 481.76±143.58 | 0.659 |
| Borg's Scale ( | 12.02±2.24 | 12.32±2.24 | 11.55±2.07 | 12.50±2.29 | 11.03±2.04 | |
| CAMCOG-R | 96.17±4.20 | 96.69±4.06 | 96.73±3.34 | 96.84±3.65 | 95.97±4.08 | 0.743 |
| MMSE | 28.64±1.43 | 28.60±1.47 | 28.80±1.18 | 28.59±1.40 | 28.80±1.26 | 0.785 |
| RAVLT: IR | 47.02±9.13 | 48.10±11.63 | 46.47±8.02 | 47.30±8.76 | 46.17±7.84 | 0.778 |
| RAVLT: STDR | 9.56±2.88 | 9.71±3.33 | 9.61±2.37 | 9.48±3.15 | 9.43±2.70 | 0.971 |
| RAVLT: LTDR | 9.14±3.35 | 9.26±3.88 | 9.24±2.45 | 8.84±3.47 | 9.29±2.92 | 0.905 |
| COWAT | 41.69±12.12 | 42.26±13.69 | 41.75±10.80 | 44.57±11.13 | 40.09±11.50 | 0.398 |
| Detection | 1.49±0.15 | 1.51±0.12 | 1.49±0.11 | 1.45±0.23 | 1.50±0.12 | 0.317 |
| One back memory | 1.31±0.18 | 1.32±0.19 | 1.30±0.19 | 1.33±0.14 | 1.33±0.17 | 0.798 |
| Groton maze learning | 68.31±28.35 | 66.02±25.81 | 66.55±27.85 | 66.30±25.40 | 65.00±17.80 | 0.993 |
| IS: visual memory | 0.05±2.02 | −0.39±1.87 | −0.04±2.02 | 0.34±2.18 | 0.36±1.98 | 0.290 |
| HADS: anxiety | 4.52±3.25 | 4.14±3.43 | 4.27±3.17 | 3.61±2.69 | 5.31±3.27 | 0.124 |
| HADS: depression | 2.82±2.28 | 2.24±1.86 | 2.84±1.90 | 2.20±1.89 | 3.03±2.12 | 0.127 |
| MFQ | 289.42±52.39 | 297.55±49.41 | 293.59±50.57 | 290.82±52.25 | 286.57±48.93 | 0.807 |
| SF-36: PC | 71.31±17.04 | 75.29±16.52 | 73.53±17.88 | 75.42±12.86 | 66.05±16.51 | |
| SF-36: MC | 76.86±15.85 | 78.42±15.75 | 80.88±12.05 | 80.50±13.00 | 73.46±16.42 | 0.090 |
Abbreviations: APOE, apolipoprotein E; BMI, body mass index; Camcog-R, Cambridge cognitive assessment-Revised; CCRT, Cambridge contextual reading test; COWAT, controlled oral word association test; HADS, hospital anxiety and depression scale; IPAQ, international physical activity questionnaire; IQ, intelligence quotient; IR, immediate recall; IS, index score; LTDR, long-term delayed recall; MFQ, memory functioning questionnaire; MMSE, mini-mental state examination; PG, post graduation; RAVLT, Rey auditory verbal learning test; SF36:PC, short form 36: physical component; SF36:MC, short form 36: mental component; STDR, short-term delayed recall.
Values are expressed as mean±s.d. unless otherwise indicated.
For all continuous variables, an analysis of variance was used and for all categorical variables, a chi-square test was used.
Indicates the group differences significant at the 0.05 level.
Figure 2Effects of the interventions on long-term delayed recall (LTDR): Repeated measures analysis of covariance showed significant group differences (P=0.040) for the LTDR scores. Post hoc analysis showed that only the combined group performed better when compared with the control group (P=0.024). Comb, combined; CS, cognitive stimulation; PA, physical activity.
Figure 3Three-dimensional stereotactic surface projection z-score images for the 16-week post-intervention scans showing regions of (a) hypometabolism and (b) hypermetabolism compared with baseline scans. COMB, combined; CS, cognitive stimulation; PA, physical activity.
Figure 4Effects of the intervention on regional count as determined by FDG-PET. (a) An ANCOVA showed significant group differences at 16 weeks post intervention in the left sensorimotor cortex (P=0.045). Post hoc analysis showed that the combined group had more glucose uptake in this region when compared with the control group (P=0.039). (b) Trends toward significant group differences (P=0.070) were observed in the left frontal cortex. Post hoc analysis revealed trends toward the combined group showing increased glucose metabolism compared with the control group (P=0.051). CS, cognitive stimulation; PA, physical activity.